Work

Evaluation of an anti-p185HER2 (scFv-CH2-CH3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-d-GEEEK

Year: 2009

Type: article

Source: Nuclear Medicine and Biology

DOI: 10.1016/j.nucmedbio.2009.04.002

Authors: Ganesan Vaidyanathan, Emmanuelle Jestin, Tove Olafsen, Anna M. Wu, Michael R. Zalutsky

Institutions: Duke Medical Center, University of California, Los Angeles

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: Astatine And Iodine Radiolabeled Monoclonal Antibodies, G118854508, Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors, Astatine and Iodine Radiolabeled Monoclonal Antibodies, The UCLA Center for In Vivo Imaging in Cancer Biology, G460175554, SRC on Primary Tumors of the CNS, Cancer Center Support Grant, Cancer Center Support Grant (CCSG)

OpenAlex ID: W1985114029

FWCI: 2.267

Cites: 55

Cited by: 20

Related to: 10